188 related articles for article (PubMed ID: 21996143)
1. Relation of serum parathyroid hormone level to severity of heart failure.
Altay H; Zorlu A; Binici S; Bilgi M; Yilmaz MB; Colkesen Y; Erol T; Muderrisoglu H
Am J Cardiol; 2012 Jan; 109(2):252-6. PubMed ID: 21996143
[TBL] [Abstract][Full Text] [Related]
2. Serum intact parathyroid hormone levels predict hospitalisation for heart failure.
Sugimoto T; Tanigawa T; Onishi K; Fujimoto N; Matsuda A; Nakamori S; Matsuoka K; Nakamura T; Koji T; Ito M
Heart; 2009 Mar; 95(5):395-8. PubMed ID: 19001003
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
[TBL] [Abstract][Full Text] [Related]
4. [Serum parathyroid hormone levels predict hospitalization in outpatients of heart failure: a preliminary study].
Wu GY; Zong GJ; Chen JK; Chen MQ; Xia Y; Wang X; Wang LL; Shi YC; Wang TX; Wang XY; Jin WD
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2205-8. PubMed ID: 24169329
[TBL] [Abstract][Full Text] [Related]
5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
6. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of parathyroid hormone as a predictor of heart failure with preserved ejection fraction.
Altay H; Zorlu A; Bilgi M; Erol T; Yilmaz MB
Biomarkers; 2012 Aug; 17(5):447-54. PubMed ID: 22582762
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide levels in obese patients with advanced heart failure.
Horwich TB; Hamilton MA; Fonarow GC
J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
[TBL] [Abstract][Full Text] [Related]
10. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
11. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure.
Sugimoto T; Dohi K; Onishi K; Watanabe K; Sato Y; Sugiura E; Nakamori S; Nakajima H; Nakamura M; Ito M
Heart; 2013 Jan; 99(2):111-5. PubMed ID: 23184010
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
[TBL] [Abstract][Full Text] [Related]
16. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
[TBL] [Abstract][Full Text] [Related]
17. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
Gruson D; Ahn SA; Rousseau MF
Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
[TBL] [Abstract][Full Text] [Related]
18. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
